ArticleHuman vaccines & immunotherapeutics2019

RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.